topic

HEPATITIS B VIRUS CO-INFECTION IS ASSOCIATED WITH INCREASED ALL-CAUSE MORTALITY AMONG HIV-INFECTED ADULTS ON TENOFOVIR-DISOPROXIL-FUMARATE CONTAINING ANTIRETROVIRAL THERAPY IN LUSAKA, ZAMBIA
Michael Vinikoor, Roma Chilengi, Lloyd Mulenga, Callistus Kaayunga, Zude Zyambo, Mary-Ann Davies, Matthias Egger, Gilles Wandeler

BMJ Global Health Feb 2017, 2 (Suppl 2) A40; DOI: 10.1136/bmjgh-2016-000260.106
CAN HIV TREATMENTS INFORM OTHER CONTEXTS? A TRIAL OF AN ADDITIONAL INDICATION FOR CO-TRIMOXAZOLE PROPHYLAXIS
Moses Ngari, Johnstone Thitiri, Laura Mwalekwa, Greg Fegan, James Berkley

BMJ Global Health Feb 2017, 2 (Suppl 2) A41; DOI: 10.1136/bmjgh-2016-000260.108
CRYPTOCOCCAL MENINGOENCEPHALITIS IN HIV-INFECTED PATIENTS IN MADAGASCAR: HIGH PREVALENCE AND LETHALITY AND THERAPEUTIC CHALLENGES
Rivo Rakotoarivelo, Mihaja Raberahona, Njary Randriamampionona, Rabezanahary Andriamihaja, Tahinamandranto Rasamoelina, Muriel Cornet, Mamy Jean De Dieu Randria, Thomas Benet, Philippe Vanhems, Mala Rakoto Andrianarivelo

BMJ Global Health Feb 2017, 2 (Suppl 2) A42-A43; DOI: 10.1136/bmjgh-2016-000260.112
FACTORS AFFECTING ANTIRETROVIRAL DRUG ADHERENCE AMONG HIV ADULT PATIENTS ATTENDING HIV CLINIC AT THE UNIVERSITY TEACHING HOSPITAL IN LUSAKA
Uchizi Chirwa, Charles Michelo, Rosalia Dambe, Raymond Hamoonga

BMJ Global Health Feb 2017, 2 (Suppl 2) A43; DOI: 10.1136/bmjgh-2016-000260.113
THE BURDEN AND FUTURE SCOPE FOR IMPORTANT VIRAL ENTERIC PATHOGENS IN AFRICA
Duncan Steele

BMJ Global Health Feb 2017, 2 (Suppl 2) A11; DOI: 10.1136/bmjgh-2016-000260.25
IMPACT OF TARGETED INTERVENTIONS AGAINST DIARRHOEA IN ZAMBIA
Roma Chilengi, Michelo Simuyandi, Laura Beres, Samuel Bosomprah

BMJ Global Health Feb 2017, 2 (Suppl 2) A12; DOI: 10.1136/bmjgh-2016-000260.27
ONE-YEAR SAFETY OF THE RVSV∆G-ZEBOV-GP VACCINE IN ADOLESCENTS AND CHILDREN IN LAMBARENE, GABON
Bache Emmanuel Bache, José F. Fernandes, Régis M Obiang Mba, Anita L. Kabwende, Martin P. Grobusch, Sanjeev Krishna, Peter G. Kremsner, Agnandji Selidji Todagbe

BMJ Global Health Feb 2017, 2 (Suppl 2) A13; DOI: 10.1136/bmjgh-2016-000260.30
MASS DRUG ADMINISTRATION (MDA) INTEGRATED MALARIA ELIMINATION IN A HYPO-ENDEMIC ISLAND IN LAKE VICTORIA, KENYA
Jesse Gitaka, Chim Chan, James Kongere, Wataru Kagaya, Akira Kaneko

BMJ Global Health Feb 2017, 2 (Suppl 2) A14; DOI: 10.1136/bmjgh-2016-000260.33
IMMUNOGENS DESIGNED FOR TARGETING NEUTRALIZING EPITOPES OF HIV-1 ENVELOPE GLYCOPROTEIN
Godwin Nchinda, Alain Bopda, Nadesh Nji, Georgia Ambada, Loveline Ngu, Jules Tchadji, Carol Sake, Suzanne Magagoum, Ghislain D. Njambe, Abel Lisom, Chae Gyu Park

BMJ Global Health Feb 2017, 2 (Suppl 2) A15; DOI: 10.1136/bmjgh-2016-000260.36
OCCURRENCE OF DAY 3 SUBMICROSCOPIC PLASMODIUM FALCIPARUM PARASITAEMIA BEFORE AND AFTER IMPLEMENTATION OF ARTEMETHER-LUMEFANTRINE TREATMENT POLICY IN TANZANIA
Billy Ngasala, Irina Jovel, Maja Malmberg, Bruno Mmbando, Anders Björkman, Zul Premji, Andreas Mårtensson, Richard Mwaiswelo

BMJ Global Health Feb 2017, 2 (Suppl 2) A16-A17; DOI: 10.1136/bmjgh-2016-000260.40

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages